Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

The tau A0 allele in Parkinson's disease.

Identifieur interne : 000501 ( Ncbi/Curation ); précédent : 000500; suivant : 000502

The tau A0 allele in Parkinson's disease.

Auteurs : L I Golbe [États-Unis] ; A M Lazzarini ; J R Spychala ; W G Johnson ; E S Stenroos ; M H Mark ; J I Sage

Source :

RBID : pubmed:11391737

English descriptors

Abstract

Parkinson's disease (PD) is primarily an alpha-synucleinopathy, rather than a tauopathy, but there is evidence for an indirect association of tau with the pathogenetic process in PD. We therefore assessed the frequency in PD of the tau A0 allele, a dinucleotide repeat marker that has been associated with a sporadic tauopathy, progressive supranuclear palsy (PSP). We found the A0 allele to comprise 79.2% of 758 alleles from PD patients and 71.2% of 264 control alleles (P = 0.008). We also performed a meta-analysis of three previous reports, two of which failed to produce statistically significant results. Taken together, they also support a PD/A0 allelic association, even after correction for misdiagnosis of PSP as PD (P< 0.001). The A0/A0 genotype frequency in our patients (62.3%) did not differ significantly from that in controls (53.0%, P = 0.062), but the meta-analysis, even after correction for misdiagnosis, showed a significant result, with P = 0.002. The frequency of A0 allele and the A0/A0 genotype were compatible with Hardy-Weinberg equilibrium. The frequency of the A0 allele and the A0/A0 genotype in our patients with familial PD was not significantly greater than in those with sporadic PD. We conclude that the tau protein may play a small role in the pathogenesis of PD and that biochemical characterization of this role may suggest opportunities for PD prophylaxis.

PubMed: 11391737

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:11391737

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">The tau A0 allele in Parkinson's disease.</title>
<author>
<name sortKey="Golbe, L I" sort="Golbe, L I" uniqKey="Golbe L" first="L I" last="Golbe">L I Golbe</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Neurology, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901, USA. golbe@umdnj.edu</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901</wicri:regionArea>
<wicri:noRegion>New Jersey 08901</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lazzarini, A M" sort="Lazzarini, A M" uniqKey="Lazzarini A" first="A M" last="Lazzarini">A M Lazzarini</name>
</author>
<author>
<name sortKey="Spychala, J R" sort="Spychala, J R" uniqKey="Spychala J" first="J R" last="Spychala">J R Spychala</name>
</author>
<author>
<name sortKey="Johnson, W G" sort="Johnson, W G" uniqKey="Johnson W" first="W G" last="Johnson">W G Johnson</name>
</author>
<author>
<name sortKey="Stenroos, E S" sort="Stenroos, E S" uniqKey="Stenroos E" first="E S" last="Stenroos">E S Stenroos</name>
</author>
<author>
<name sortKey="Mark, M H" sort="Mark, M H" uniqKey="Mark M" first="M H" last="Mark">M H Mark</name>
</author>
<author>
<name sortKey="Sage, J I" sort="Sage, J I" uniqKey="Sage J" first="J I" last="Sage">J I Sage</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2001">2001</date>
<idno type="RBID">pubmed:11391737</idno>
<idno type="pmid">11391737</idno>
<idno type="wicri:Area/PubMed/Corpus">003D50</idno>
<idno type="wicri:Area/PubMed/Curation">003D50</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003C23</idno>
<idno type="wicri:Area/Ncbi/Merge">000501</idno>
<idno type="wicri:Area/Ncbi/Curation">000501</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">The tau A0 allele in Parkinson's disease.</title>
<author>
<name sortKey="Golbe, L I" sort="Golbe, L I" uniqKey="Golbe L" first="L I" last="Golbe">L I Golbe</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Neurology, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901, USA. golbe@umdnj.edu</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901</wicri:regionArea>
<wicri:noRegion>New Jersey 08901</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lazzarini, A M" sort="Lazzarini, A M" uniqKey="Lazzarini A" first="A M" last="Lazzarini">A M Lazzarini</name>
</author>
<author>
<name sortKey="Spychala, J R" sort="Spychala, J R" uniqKey="Spychala J" first="J R" last="Spychala">J R Spychala</name>
</author>
<author>
<name sortKey="Johnson, W G" sort="Johnson, W G" uniqKey="Johnson W" first="W G" last="Johnson">W G Johnson</name>
</author>
<author>
<name sortKey="Stenroos, E S" sort="Stenroos, E S" uniqKey="Stenroos E" first="E S" last="Stenroos">E S Stenroos</name>
</author>
<author>
<name sortKey="Mark, M H" sort="Mark, M H" uniqKey="Mark M" first="M H" last="Mark">M H Mark</name>
</author>
<author>
<name sortKey="Sage, J I" sort="Sage, J I" uniqKey="Sage J" first="J I" last="Sage">J I Sage</name>
</author>
</analytic>
<series>
<title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint>
<date when="2001" type="published">2001</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Aged</term>
<term>Alleles</term>
<term>Case-Control Studies</term>
<term>Female</term>
<term>Gene Frequency</term>
<term>Genetic Markers</term>
<term>Genotype</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Nerve Tissue Proteins (genetics)</term>
<term>Parkinson Disease (classification)</term>
<term>Parkinson Disease (genetics)</term>
<term>Protein Isoforms</term>
<term>Supranuclear Palsy, Progressive (genetics)</term>
<term>Synucleins</term>
<term>tau Proteins (genetics)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Nerve Tissue Proteins</term>
<term>tau Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en">
<term>Genetic Markers</term>
<term>Protein Isoforms</term>
<term>Synucleins</term>
</keywords>
<keywords scheme="MESH" qualifier="classification" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Parkinson Disease</term>
<term>Supranuclear Palsy, Progressive</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Aged</term>
<term>Alleles</term>
<term>Case-Control Studies</term>
<term>Female</term>
<term>Gene Frequency</term>
<term>Genotype</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Parkinson's disease (PD) is primarily an alpha-synucleinopathy, rather than a tauopathy, but there is evidence for an indirect association of tau with the pathogenetic process in PD. We therefore assessed the frequency in PD of the tau A0 allele, a dinucleotide repeat marker that has been associated with a sporadic tauopathy, progressive supranuclear palsy (PSP). We found the A0 allele to comprise 79.2% of 758 alleles from PD patients and 71.2% of 264 control alleles (P = 0.008). We also performed a meta-analysis of three previous reports, two of which failed to produce statistically significant results. Taken together, they also support a PD/A0 allelic association, even after correction for misdiagnosis of PSP as PD (P< 0.001). The A0/A0 genotype frequency in our patients (62.3%) did not differ significantly from that in controls (53.0%, P = 0.062), but the meta-analysis, even after correction for misdiagnosis, showed a significant result, with P = 0.002. The frequency of A0 allele and the A0/A0 genotype were compatible with Hardy-Weinberg equilibrium. The frequency of the A0 allele and the A0/A0 genotype in our patients with familial PD was not significantly greater than in those with sporadic PD. We conclude that the tau protein may play a small role in the pathogenesis of PD and that biochemical characterization of this role may suggest opportunities for PD prophylaxis.</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000501 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 000501 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:11391737
   |texte=   The tau A0 allele in Parkinson's disease.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i   -Sk "pubmed:11391737" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a MovDisordV3 

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024